US Patent Issued to Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital on April 21 for "Methods and compositions of inhibiting DCN1-UBC12 interaction" (Tennessee, New York, Arkansas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,373, issued on April 21, was assigned to Memorial Sloan Kettering Cancer Center (New York) and St. Jude Children's Research Hospital Inc. (Memphis, Tenn.).

"Methods and compositions of inhibiting DCN1-UBC12 interaction" was invented by Jaeki Min (Memphis, Tenn.), Daniel C. Scott (Marion, Ark.), Deepak Bhasin (Cordova, Tenn.), Brenda A. Schulman (Memphis, Tenn.), Bhuvanesh Singh (Old Westbury, N.Y.), Jared T. Hammill (Memphis, Tenn.) and R. Kiplin Guy (Memphis, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the invention relates to substituted 1-phenyl-3-(piperidin-4-yl)urea analogs, derivatives thereof, and related compounds, w...